Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS

References

• Rapoport M, Bloch O. Systemic lupus erythematosus. N Engl J Med. 2012;366(6):574–4.
   PubMed Web of Science ®Google Scholar
• Sui W, Hou X, Che W, Yang M, Dai Y. The applied basic research of systemic lupus erythematosus based on the biological omics. Genes Immun. 2013;14(3):133–46.
   PubMed Web of Science ®Google Scholar
• Ceccarelli F, Perricone C, Massaro L, Cipriano E, Alessandri C, Spinelli FR, et al. Assessment of disease activity in systemic lupus erythematosus: lights and shadows. Autoimmun Rev. 2015;14(7):601–8.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Arriens C, Mohan C. Systemic lupus erythematosus diagnostics in the ‘omics’ era. Int J Clin Rheumtol. 2013;8(6):671–87.
   PubMedGoogle Scholar
• Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol. 2000;53(6):424–32.
   PubMed Web of Science ®Google Scholar
• Russell AI, Cunninghame Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet. 2004;13(1):137–47.
   PubMed Web of Science ®Google Scholar
• Baechler EC, Gregersen PK, Behrens TW. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol. 2004;16(6):801–7.
   PubMed Web of Science ®Google Scholar
• Crow MK. Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheum Dis Clin North Am. 2010;36(1):173–86.
   PubMed Web of Science ®Google Scholar
• Reveille JD. Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus. 2004;13(5):290–7.
   PubMed Web of Science ®Google Scholar
• Dorner T, Lipsky PE. Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus. Lupus. 2004;13(5):283–9.
   PubMed Web of Science ®Google Scholar
• Manzi S, Navratil JS, Ruffing MJ, Liu CC, Danchenko N, Nilson SE, et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum. 2004;50(11): 3596–604.
   PubMed Web of Science ®Google Scholar
• Zhang A, Sun H, Yan G, Wang P, Wang X. Metabolomics for biomarker discovery: moving to the clinic. Biomed Res Int. 2015: 2015;354671.
   PubMed Web of Science ®Google Scholar
• Chen L, Luo Z, Fu W, Liao X, Cui Z, Zhou J. Detection of urinary metabolomics before and after Pringle maneuver-induced liver ischemia and reperfusion injury in rats using gas chromatography–mass spectrometry. Dis Markers. 2013;35(5):345–51.
   Google Scholar
• Ouyang X, Dai Y, Wen JL, Wang LX. (1)H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus. Lupus. 2011;20(13):1411–20.
   PubMed Web of Science ®Google Scholar
• Yu Y, Cao Y, Chen Y, Wen C, Xu Z. Plasma metabonomics study of systemic lupus erythematosus based on liquid chromatography–mass spectrometry. Se Pu. 2010;28(7):644–8.
   PubMedGoogle Scholar
• Wu T, Xie C, Han J, Ye Y, Weiel J, Li Q, et al. Metabolic disturbances associated with systemic lupus erythematosus. PLoS One. 2012;7(6):e37210.
   PubMed Web of Science ®Google Scholar
• Saegusa J, Irino Y, Yoshida M, Tanaka S, Kogata Y, Kageyama G, et al. GC/MS-based metabolomics detects metabolic alterations in serum from SLE patients. Clin Exp Rheumatol. 2014;32(1):148.
   PubMed Web of Science ®Google Scholar
• Theodoridis G, Gika HG, Wilson ID. Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. Mass Spectrom Rev. 2011;30(5):884–906.
   PubMed Web of Science ®Google Scholar
• Li M, Wang X, Aa J, Qin W, Zha W, Ge Y, et al. GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy. Am J Physiol Renal Physiol. 2013;304(11):F1317–24.
   PubMed Web of Science ®Google Scholar
• Xia J, Sinelnikov IV, Han B, Wishart DS. MetaboAnalyst 3.0 – making metabolomics more meaningful. Nucleic Acids Res. 2015;43(W1):W251–7.
   PubMed Web of Science ®Google Scholar
• Gergely P Jr, Grossman C, Niland B, Puskas F, Neupane H, Allam F, et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 2002;46(1):175–90.
   PubMed Web of Science ®Google Scholar
• Perl A, Hanczko R, Doherty E. Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol Biol. 2012;900:61–89.
   PubMedGoogle Scholar
• Shishkin VI, Kudriavtseva GV, Makarov SA. Pentose phosphate pathway of carbohydrate metabolism in various systemic diseases of the connective tissue. Vopr Med Khim. 1988;34(6):40–5.
   PubMed Web of Science ®Google Scholar
• Fernandez D, Bonilla E, Phillips P, Perl A. Signaling abnormalities in systemic lupus erythematosus as potential drug targets. Endocr Metab Immune Disord Drug Targets. 2006;6(4):305–11.
   PubMedGoogle Scholar
• Fan J, Hong J, Hu JD, Chen JL. Ion chromatography based urine amino acid profiling applied for diagnosis of gastric cancer. Gastroenterol Res Pract. 2012;2012:474907.
   PubMed Web of Science ®Google Scholar
• Wang XY, Li N, Gu J, Li WQ, Li JS. The effects of the formula of amino acids enriched BCAA on nutritional support in traumatic patients. World J Gastroenterol. 2003;9(3):599–602.
   PubMed Web of Science ®Google Scholar
• Perl A. Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment. Autoimmunity. 2010;43(1):32–47.
   PubMed Web of Science ®Google Scholar
• Shah D, Sah S, Nath SK. Interaction between glutathione and apoptosis in systemic lupus erythematosus. Autoimmun Rev. 2012;12(7):741–51.
   PubMed Web of Science ®Google Scholar
• Yang Z, Matteson EL, Goronzy JJ, Weyand CM. T-cell metabolism in autoimmune disease. Arthritis Res Ther. 2015;17:29.
   PubMed Web of Science ®Google Scholar
• Anderson ME. Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact. 1998;111–112:1–14.
   PubMed Web of Science ®Google Scholar
• Song W, Yuan J, Zhang Z, Li L, Hu L. Altered glutamate cysteine ligase activity in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Exp Ther Med. 2014;8(1):195–200.
   PubMed Web of Science ®Google Scholar
• Copley SD, Frank E, Kirsch WM, Koch TH. Detection and possible origins of aminomalonic acid in protein hydrolysates. Anal Biochem. 1992;201(1):152–7.
   PubMed Web of Science ®Google Scholar
• Thomas M, Hughes RE. A relationship between ascorbic acid and threonic acid in guinea-pigs. Food Chem Toxicol. 1983;21(4):449–52.
   PubMed Web of Science ®Google Scholar
• Tauler P, Aguilo A, Gimeno I, Fuentespina E, Tur JA, Pons A. Influence of vitamin C diet supplementation on endogenous antioxidant defences during exhaustive exercise. Pflugers Arch. 2003;446(6):658–64.
   PubMed Web of Science ®Google Scholar
• Widner B, Sepp N, Kowald E, Ortner U, Wirleitner B, Fritsch P, et al. Enhanced tryptophan degradation in systemic lupus erythematosus. Immunobiology. 2000;201(5):621–30.
   PubMed Web of Science ®Google Scholar
• Widner B, Sepp N, Kowald E, Kind S, Schmuth M, Fuchs D. Degradation of tryptophan in patients with systemic lupus erythematosus. Adv Exp Med Biol. 1999;467:571–7.
   PubMed Web of Science ®Google Scholar
• Wirleitner B, Rudzite V, Neurauter G, Murr C, Kalnins U, Erglis A, et al. Immune activation and degradation of tryptophan in coronary heart disease. Eur J Clin Invest. 2003;33(7):550–4.
   PubMed Web of Science ®Google Scholar
• Sikalidis AK. Amino acids and immune response: a role for cysteine, glutamine, phenylalanine, tryptophan and arginine in T-cell function and cancer? Pathol Oncol Res. 2015;21(1):9–17.
   PubMed Web of Science ®Google Scholar
• Cagnoli P, Harris RE, Frechtling D, Berkis G, Gracley RH, Graft CC, et al. Reduced insular glutamine and N-acetylaspartate in systemic lupus erythematosus: a single-voxel (1)H-MR spectroscopy study. Acad Radiol. 2013;20(10):1286–96.
   PubMed Web of Science ®Google Scholar
• Posadas-Romero C, Torres-Tamayo M, Zamora-Gonzalez J, Aguilar-Herrera BE, Posadas-Sanchez R, Cardoso-Saldana G, et al. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus. Arthritis Rheum. 2004;50(1):160–5.
   PubMed Web of Science ®Google Scholar
• Miccheli A, Capuani G, Marini F, Tomassini A, Pratico G, Ceccarelli S, et al. Urinary H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. Int J Obes (Lond). 2015;39(7):1118–25.
   PubMed Web of Science ®Google Scholar
• Elliott P, Posma JM, Chan Q, Garcia-Perez I, Wijeyesekera A, Bictash M, et al. Urinary metabolic signatures of human adiposity. Sci Transl Med. 2015;7(285):285ra62.
   PubMed Web of Science ®Google Scholar
• Bordag N, Klie S, Jurchott K, Vierheller J, Schiewe H, Albrecht V, et al. Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects. Sci Rep. 2015;5:15954.
   PubMed Web of Science ®Google Scholar